How do I buy Tilray Brands, Inc. Common Stock (TLRY) stock?

Buying Tilray Brands, Inc. Common Stock (TLRY) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "TLRY", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy TLRY by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if TLRY is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Tilray Brands, Inc. Common Stock (TLRY) Stock

Q: What is the minimum investment for TLRY on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Tilray Brands, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NSQ · TLRY

Trade TLRY

Key stats

Market cap: $385.73M
Price / Earnings ratio: -2.4x
EPS (TTM): -$1.41
Volume: Loading
52-week high: $15.70
52-week low: $0.77
EPS vs analyst estimate: +100.0%Q1 FY26 · $0.00 vs -$0.01

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with TLRY

Technical indicators

RSI 14: 34.83
MACD 12/26/9: -0.22
EMA 9 of MACD: -0.26
MACD histogram: 0.04
SMA 50: $3.48; Price below SMA 50
EMA 50: $3.37; Price below EMA 50
SMA 200: $5.22; Price below SMA 200
EMA 200: $5.43; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

No analyst data available

Financials

Performance

Revenue

Net income

Net margin %

2022

2023

2024

2025

2026

1B725M363M0

Debt & Balance Sheet

Total assets

Total liabilities

2022

2023

2024

2025

2026

7B4B2B0

Revenue to Profit

2026

$915.5M

Revenue

$0.0

Cost of revenue

$260.4M

Gross profit

$0.0

Operating expenses

$-121.4M

Net income

Earnings

EPS forecast

Actual EPS

$0.00

$-0.01

Q1FY26

$-0.01

Q2FY26

$0.01

Q3FY26

$-0.02

Q4FY26

$-0.02

Q1FY27

The market is expecting earnings per share of -$0.02 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Tilray Brands, Inc. Common Stock

Tilray is a global pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Tilray was the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP) certified in accordance with European Medicine Agency (EMA) standards.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees3,595

CEOMr. Irwin David Simon

IPO DateJul 19, 2018

HeadquartersLeamington, ON

Key Executives

Name	Title	Year Born
Mr. Irwin David Simon	President, CEO & Chairman	1958
Mr. Carl A. Merton CA, CBV, CPA	CFO & Principal Accounting Officer	1970
Mr. Mitchell S. Gendel J.D.	Global General Counsel & Corporate Secretary	1966
Ms. Denise Menikheim Faltischek	Chief Strategy Officer and Head of M&A	1973
Mr. Lloyd Brathwaite	Chief Information Officer	—
Ms. Nyree Pinto	Chief Human Resources Officer	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-22.3	-24.2
2022	-19.4	-1.9	+32.8	-33.4	-14.1	-25.4	+15.9	+11.1	-23.2	+41.8	+1.3	-35.5
2023	+17.8	-15.0	-8.0	-7.5	-26.8	-8.2	+49.7	+24.4	-20.1	-20.7	+4.6	+21.1
2024	-17.6	-11.7	+42.8	+1.6	-10.9	-7.5	+20.8	-14.1	+4.8	-2.4	-18.3	-0.7
2025	-28.1	-25.8	-3.7	-25.8	-12.3	+1.7	+37.7	+142.5	+38.4	-19.0	-37.9	+15.5
2026	-23.3	+5.8	-14.9	+1.6	-10.6	-18.2	+2.5	-1.5	-16.7	-29.1	+3.9

Stocks in the same sector

Amneal Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc

ANIP

ANI Pharmaceuticals Inc

FAQ

Buying Tilray Brands, Inc. Common Stock (TLRY) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "TLRY", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy TLRY by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Tilray Brands, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Tilray Brands, Inc. Common Stock (TLRY) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TLRY's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Tilray Brands, Inc. Common Stock (TLRY) Stock

Key stats

Compare with TLRY

Recent news

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?

Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

3 Huge Red Flags From Tilray's Q1 Earnings Report

3 Huge Red Flags From Tilray's Q1 Earnings Report

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform

About Tilray Brands, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade